Tyra Biosciences, Inc. TYRA Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s operating lease liabilities (total)?
- Tyra Biosciences, Inc. (TYRA) reported operating lease liabilities (total) of $5.7M in Q1 2026.
- How has Tyra Biosciences, Inc.'s operating lease liabilities (total) changed year-over-year?
- Tyra Biosciences, Inc.'s operating lease liabilities (total) decreased by 6.9% year-over-year, from $6.12M to $5.7M.
- What is the long-term trend for Tyra Biosciences, Inc.'s operating lease liabilities (total)?
- Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s operating lease liabilities (total) has grown at a 48.9% compound annual growth rate (CAGR), from $1.18M to $5.81M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.